Product Images Bupropion Hydrochloride

This is a warning label for 60 tablets of buPROPion hydrochloride extended-release 100mg tablets. It cautions against using the medication with other products containing bupropion hydrochloride, including ZYBAN. The pharmacist is advised to dispense the medication guide to each patient separately. The label includes the NDC code and a lot number. Full labeling information is available but not provided in this text.*

Each extended-release tablet contains 150mg of bupropion hydrochloride. It is manufactured by Sun Pharmaceutical Industries in Halol, Gujarat, India. The tablets should be stored between 20°C to 25°C (66°F to 77°F) and excursions are permitted to 15°C to 30°C (59°F to 86°F). The usual dosage should be taken twice a day, and it is important not to use the medication if the safety seal under the cap is broken or missing. This medication should not be used in combination with Zyban, or any other medication that contains bupropion hydrochloride. ZYBAN is a registered trademark of the manufacturer GlaxoSmithKline. The medication comes in a tight, light-resistant container and is distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ.*

Each extended-release tablet contains 200 mg bupropion HCI, USP, for usual dosage information see package insert. Store at controlled room temperature between 20°to 25°C (68° 10 7°F); excursions permitied to 15° to 30°C (59° 10 86°F). Dispense in a tight, light-resistant container. Do not use if safety seal under cap is broken or missing. Warning not to use in combination with other medicines that contain bupropion hydrochioride. The product is distributed by Sun Pharmaceutical Industries, Inc. manufacturing details are given at the end of the text.*